Andrew Geall

Andrew Geall

Company: Replicate Bioscience

Job title: Chief Development Officer


Panel Discussion: Reviewing Standards & Regulatory Requirements of the Analytical Field of mRNA-Based Therapeutics 8:45 am

Delving into how to give evidence of a state of control and maintain regulatory compliance for your mRNA analytical techniques Revealing how to integrate the new novel mRNA analytical technologies to align to GMP guidelines Understanding how to standardize your mRNA analytical techniques to align to CQAs and CPIs to allow efficient and rapid approvalRead more

day: Day Two

Developing Different Types of Potency Assays to Measure Contaminants & Bioreactivity of mRNA-Based Therapeutics 2:30 pm

Investigating the development of novel purity assays to improve the efficacy of mRNA-based therapeutics  Exploring the development of different types of potency assays that can accurately measure the bioreactivity of mRNA-based therapeutics to ensure the safety and efficacy of these therapeutics for patients Investigating the available different approaches to show bioactivity in cell culture to…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.